Fan Jiaqi, Liu Xianbao, Yu Lei, Sun Yinghao, Jaiswal Sanjay, Zhu Qifeng, Chen Han, He Yuxin, Wang Lihan, Ren Kaida, Wang Jian'an
Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Clin Cardiol. 2019 Jan;42(1):206-212. doi: 10.1002/clc.23126. Epub 2018 Dec 22.
Far less attention has been paid to the prognostic effect of right-side heart disease on outcomes after transcatheter aortic valve replacement (TAVR) when compared with the left side. Therefore, we performed a systematic review and meta-analysis on the impact of tricuspid regurgitation (TR) and right ventricular (RV) dysfunction on outcomes after TAVR. We hypothesized that TR and RV dysfunction may have a deleterious effect on outcomes after TAVR. Article revealing the prognostic effect of TR and RV dysfunction on outcomes after TAVR were being integrated. Random or fixed effect model was adopted in accordance with the heterogeneity. There were nine studies with a total of 6466 patients enrolled after a comprehensive literature search of the MEDLINE/PubMed, EMBASE, ISI Web of Science, and Cochrane databases. The overall analysis revealed that moderate or severe TR at baseline increased all-cause mortality after TAVR (HR = 1.79, CI 95% 1.52-2.11, P < 0.001). Both baseline RV dysfunction (HR = 1.53, CI 95% 1.27-1.83, P < 0.001) and presence of RV dilation (HR = 1.83, CI 95% 1.47-2.27, P < 0.001) were associated with all-cause mortality. Both baseline moderate or severe TR and RV dysfunction worsen prognosis after TAVR and careful assessment of right heart function should be done for clinical decision by the heart team before the TAVR procedure.
与左侧相比,经导管主动脉瓣置换术(TAVR)后右侧心脏病对预后的影响受到的关注要少得多。因此,我们对三尖瓣反流(TR)和右心室(RV)功能障碍对TAVR后预后的影响进行了系统评价和荟萃分析。我们假设TR和RV功能障碍可能对TAVR后的预后产生有害影响。纳入揭示TR和RV功能障碍对TAVR后预后影响的文章。根据异质性采用随机或固定效应模型。在对MEDLINE/PubMed、EMBASE、ISI科学网和Cochrane数据库进行全面文献检索后,共有9项研究纳入了6466例患者。总体分析显示,基线时中度或重度TR会增加TAVR后的全因死亡率(HR = 1.79,95%CI 1.52 - 2.11,P < 0.001)。基线RV功能障碍(HR = 1.53,95%CI 1.27 - 1.83,P < 0.001)和RV扩张的存在(HR = 1.83,95%CI 1.47 - 2.27,P < 0.001)均与全因死亡率相关。基线时中度或重度TR和RV功能障碍都会使TAVR后的预后恶化,心脏团队在TAVR手术前应仔细评估右心功能,以便做出临床决策。